APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Reference Substance (CMRS)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Chinese Medicine Reference Substance (CMRS) Industry Research Report 2026

23 December 2025123 pages

Choose your research edition.

Industry ResearchChinese Medicine Reference Substance (CMRS) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Reference Substance (CMRS) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Reference Substance (CMRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Reference Substance (CMRS) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Reference Substance (CMRS) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chinese Medicine Reference Substance (CMRS) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Chinese Medicine Reference Substance (CMRS) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Chinese Medicine Reference Substance (CMRS) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Reference Substance (CMRS) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Chinese Medicine Reference Substance (CMRS) include Baoji Herbest Bio-Tech, ChemFaces, ChromaDex, Diagnocine, PhytoLab, Derick, Desite, GeLiPuBio and Chengdu Must Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Chinese Medicine Reference Substance (CMRS) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Chinese Medicine Reference Substance (CMRS) Market by Company

Baoji Herbest Bio-Tech

ChemFaces

ChromaDex

Diagnocine

PhytoLab

Derick

Desite

GeLiPuBio

Chengdu Must Biotechnology

Purechemland

Nature Standard

RENI Pharmaceutical Technology

Chinese Medicine Reference Substance (CMRS) Segment by Type

Plant-Derived Reference Substances

Mineral-Derived Reference Substances

Chemically Synthesized Reference Substances

Animal-Derived Reference Substances

Chinese Medicine Reference Substance (CMRS) Segment by Application

Pharmaceutical Identification

Pharmaceutical Development

Chinese Medicine Reference Substance (CMRS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Reference Substance (CMRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Reference Substance (CMRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Reference Substance (CMRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Chinese Medicine Reference Substance (CMRS) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Chinese Medicine Reference Substance (CMRS) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Chinese Medicine Reference Substance (CMRS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chinese Medicine Reference Substance (CMRS) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Chinese Medicine Reference Substance (CMRS) Sales (k units) of Manufacturers (2021-2026) Table 7. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Chinese Medicine Reference Substance (CMRS) Revenue of Manufacturers (2021-2026) Table 9. Global Chinese Medicine Reference Substance (CMRS) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Chinese Medicine Reference Substance (CMRS) Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Chinese Medicine Reference Substance (CMRS) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Product Type & Application Table 14. Global Chinese Medicine Reference Substance (CMRS) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Chinese Medicine Reference Substance (CMRS) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Baoji Herbest Bio-Tech Company Information Table 19. Baoji Herbest Bio-Tech Business Overview Table 20. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 22. Baoji Herbest Bio-Tech Recent Developments Table 23. ChemFaces Company Information Table 24. ChemFaces Business Overview Table 25. ChemFaces Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 27. ChemFaces Recent Developments Table 28. ChromaDex Company Information Table 29. ChromaDex Business Overview Table 30. ChromaDex Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 32. ChromaDex Recent Developments Table 33. Diagnocine Company Information Table 34. Diagnocine Business Overview Table 35. Diagnocine Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 37. Diagnocine Recent Developments Table 38. PhytoLab Company Information Table 39. PhytoLab Business Overview Table 40. PhytoLab Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 42. PhytoLab Recent Developments Table 43. Derick Company Information Table 44. Derick Business Overview Table 45. Derick Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 47. Derick Recent Developments Table 48. Desite Company Information Table 49. Desite Business Overview Table 50. Desite Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 52. Desite Recent Developments Table 53. GeLiPuBio Company Information Table 54. GeLiPuBio Business Overview Table 55. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 57. GeLiPuBio Recent Developments Table 58. Chengdu Must Biotechnology Company Information Table 59. Chengdu Must Biotechnology Business Overview Table 60. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 62. Chengdu Must Biotechnology Recent Developments Table 63. Purechemland Company Information Table 64. Purechemland Business Overview Table 65. Purechemland Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 67. Purechemland Recent Developments Table 68. Nature Standard Company Information Table 69. Nature Standard Business Overview Table 70. Nature Standard Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 72. Nature Standard Recent Developments Table 73. RENI Pharmaceutical Technology Company Information Table 74. RENI Pharmaceutical Technology Business Overview Table 75. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio Table 77. RENI Pharmaceutical Technology Recent Developments Table 78. Global Chinese Medicine Reference Substance (CMRS) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2021-2026) & (k units) Table 80. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2021-2026) Table 81. Global Chinese Medicine Reference Substance (CMRS) Sales by Region (2027-2032) & (k units) Table 82. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2027-2032) Table 83. Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2021-2026) Table 85. Global Chinese Medicine Reference Substance (CMRS) Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2027-2032) Table 87. North America Chinese Medicine Reference Substance (CMRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 89. North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 90. North America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 94. Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 95. Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Chinese Medicine Reference Substance (CMRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 99. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 100. Asia Pacific Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Chinese Medicine Reference Substance (CMRS) Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Chinese Medicine Reference Substance (CMRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 104. South America Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 105. South America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2026) & (k units) Table 109. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2027-2032) & (k units) Table 110. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2026) & (k units) Table 113. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2027-2032) & (k units) Table 114. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2026) Table 115. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2027-2032) Table 116. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2026) Table 119. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2027-2032) Table 120. Global Chinese Medicine Reference Substance (CMRS) Price by Type (2021-2026) & (USD/unit) Table 121. Global Chinese Medicine Reference Substance (CMRS) Price by Type (2027-2032) & (USD/unit) Table 122. Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2026) & (k units) Table 123. Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2027-2032) & (k units) Table 124. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2026) Table 125. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2027-2032) Table 126. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2026) Table 129. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2027-2032) Table 130. Global Chinese Medicine Reference Substance (CMRS) Price by Application (2021-2026) & (USD/unit) Table 131. Global Chinese Medicine Reference Substance (CMRS) Price by Application (2027-2032) & (USD/unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Chinese Medicine Reference Substance (CMRS) Distributors List Table 135. Chinese Medicine Reference Substance (CMRS) Customers List Table 136. Chinese Medicine Reference Substance (CMRS) Industry Trends Table 137. Chinese Medicine Reference Substance (CMRS) Industry Drivers Table 138. Chinese Medicine Reference Substance (CMRS) Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Chinese Medicine Reference Substance (CMRS) Product Image Figure 5. Global Chinese Medicine Reference Substance (CMRS) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Chinese Medicine Reference Substance (CMRS) Market Size (2021-2032) & (US$ Million) Figure 7. Global Chinese Medicine Reference Substance (CMRS) Sales (2021-2032) & (k units) Figure 8. Global Chinese Medicine Reference Substance (CMRS) Average Price (USD/unit) & (2021-2032) Figure 9. Plant-Derived Reference Substances Product Image Figure 10. Mineral-Derived Reference Substances Product Image Figure 11. Chemically Synthesized Reference Substances Product Image Figure 12. Animal-Derived Reference Substances Product Image Figure 13. Pharmaceutical Identification Product Image Figure 14. Pharmaceutical Development Product Image Figure 15. Global Chinese Medicine Reference Substance (CMRS) Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Chinese Medicine Reference Substance (CMRS) Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Chinese Medicine Reference Substance (CMRS) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Chinese Medicine Reference Substance (CMRS) Sales by Region in 2025 Figure 21. Global Chinese Medicine Reference Substance (CMRS) Revenue by Region in 2025 Figure 22. North America Chinese Medicine Reference Substance (CMRS) Market Size by Country in 2025 Figure 23. North America Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 24. North America Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2021-2032) Figure 25. United States Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Chinese Medicine Reference Substance (CMRS) Market Size by Country in 2025 Figure 29. Europe Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 30. Europe Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2021-2032) Figure 31. Germany Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Chinese Medicine Reference Substance (CMRS) Market Size by Country in 2025 Figure 42. Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2021-2032) Figure 44. China Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Chinese Medicine Reference Substance (CMRS) Market Size by Country in 2025 Figure 53. South America Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 54. South America Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2021-2032) Figure 55. Brazil Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Market Size by Country in 2025 Figure 60. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2021-2032) Figure 62. Egypt Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2032) Figure 68. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2032) Figure 69. Global Chinese Medicine Reference Substance (CMRS) Price (USD/unit) by Type (2021-2032) Figure 70. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2032) Figure 71. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2032) Figure 72. Global Chinese Medicine Reference Substance (CMRS) Price (USD/unit) by Application (2021-2032) Figure 73. Chinese Medicine Reference Substance (CMRS) Value Chain Figure 74. Chinese Medicine Reference Substance (CMRS) Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Plant-Derived Reference Substances
  • Mineral-Derived Reference Substances
  • Chemically Synthesized Reference Substances
  • Animal-Derived Reference Substances
Applications
  • Pharmaceutical Identification
  • Pharmaceutical Development
Companies covered
  • Baoji Herbest Bio-Tech
  • ChemFaces
  • ChromaDex
  • Diagnocine
  • PhytoLab
  • Derick
  • Desite
  • GeLiPuBio
  • Chengdu Must Biotechnology
  • Purechemland
  • Nature Standard
  • RENI Pharmaceutical Technology

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Chinese Medicine Reference Substance (CMRS) Market Size (2021-2032)
  4. 2.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales (2021-2032)
  5. 2.2.3 Global Chinese Medicine Reference Substance (CMRS) Market Average Price (2021-2032)
  6. 2.3 Chinese Medicine Reference Substance (CMRS) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Plant-Derived Reference Substances
  9. 2.3.3 Mineral-Derived Reference Substances
  10. 2.3.4 Chemically Synthesized Reference Substances
  11. 2.3.5 Animal-Derived Reference Substances
  12. 2.4 Chinese Medicine Reference Substance (CMRS) by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Pharmaceutical Identification
  15. 2.4.3 Pharmaceutical Development
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Chinese Medicine Reference Substance (CMRS) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Chinese Medicine Reference Substance (CMRS) Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Chinese Medicine Reference Substance (CMRS) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Chinese Medicine Reference Substance (CMRS) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Chinese Medicine Reference Substance (CMRS) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Product Type & Application
  8. 3.8 Global Manufacturers of Chinese Medicine Reference Substance (CMRS), Established Date
  9. 3.9 Global Chinese Medicine Reference Substance (CMRS) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Baoji Herbest Bio-Tech
  2. 4.1.1 Baoji Herbest Bio-Tech Company Information
  3. 4.1.2 Baoji Herbest Bio-Tech Business Overview
  4. 4.1.3 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolio
  6. 4.1.5 Baoji Herbest Bio-Tech Recent Developments
  7. 4.2 ChemFaces
  8. 4.2.1 ChemFaces Company Information
  9. 4.2.2 ChemFaces Business Overview
  10. 4.2.3 ChemFaces Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolio
  12. 4.2.5 ChemFaces Recent Developments
  13. 4.3 ChromaDex
  14. 4.3.1 ChromaDex Company Information
  15. 4.3.2 ChromaDex Business Overview
  16. 4.3.3 ChromaDex Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolio
  18. 4.3.5 ChromaDex Recent Developments
  19. 4.4 Diagnocine
  20. 4.4.1 Diagnocine Company Information
  21. 4.4.2 Diagnocine Business Overview
  22. 4.4.3 Diagnocine Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolio
  24. 4.4.5 Diagnocine Recent Developments
  25. 4.5 PhytoLab
  26. 4.5.1 PhytoLab Company Information
  27. 4.5.2 PhytoLab Business Overview
  28. 4.5.3 PhytoLab Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolio
  30. 4.5.5 PhytoLab Recent Developments
  31. 4.6 Derick
  32. 4.6.1 Derick Company Information
  33. 4.6.2 Derick Business Overview
  34. 4.6.3 Derick Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Derick Chinese Medicine Reference Substance (CMRS) Product Portfolio
  36. 4.6.5 Derick Recent Developments
  37. 4.7 Desite
  38. 4.7.1 Desite Company Information
  39. 4.7.2 Desite Business Overview
  40. 4.7.3 Desite Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Desite Chinese Medicine Reference Substance (CMRS) Product Portfolio
  42. 4.7.5 Desite Recent Developments
  43. 4.8 GeLiPuBio
  44. 4.8.1 GeLiPuBio Company Information
  45. 4.8.2 GeLiPuBio Business Overview
  46. 4.8.3 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolio
  48. 4.8.5 GeLiPuBio Recent Developments
  49. 4.9 Chengdu Must Biotechnology
  50. 4.9.1 Chengdu Must Biotechnology Company Information
  51. 4.9.2 Chengdu Must Biotechnology Business Overview
  52. 4.9.3 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  54. 4.9.5 Chengdu Must Biotechnology Recent Developments
  55. 4.10 Purechemland
  56. 4.10.1 Purechemland Company Information
  57. 4.10.2 Purechemland Business Overview
  58. 4.10.3 Purechemland Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolio
  60. 4.10.5 Purechemland Recent Developments
  61. 4.11 Nature Standard
  62. 4.11.1 Nature Standard Company Information
  63. 4.11.2 Nature Standard Business Overview
  64. 4.11.3 Nature Standard Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolio
  66. 4.11.5 Nature Standard Recent Developments
  67. 4.12 RENI Pharmaceutical Technology
  68. 4.12.1 RENI Pharmaceutical Technology Company Information
  69. 4.12.2 RENI Pharmaceutical Technology Business Overview
  70. 4.12.3 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolio
  72. 4.12.5 RENI Pharmaceutical Technology Recent Developments
5 Global Chinese Medicine Reference Substance (CMRS) Market Scenario by Region
  1. 5.1 Global Chinese Medicine Reference Substance (CMRS) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021-2032
  3. 5.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2021-2026
  4. 5.2.2 Global Chinese Medicine Reference Substance (CMRS) Sales by Region: 2027-2032
  5. 5.3 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region: 2021-2032
  6. 5.3.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region: 2021-2026
  7. 5.3.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Region: 2027-2032
  8. 5.4 North America Chinese Medicine Reference Substance (CMRS) Market Facts & Figures by Country
  9. 5.4.1 North America Chinese Medicine Reference Substance (CMRS) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  11. 5.4.3 North America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Chinese Medicine Reference Substance (CMRS) Market Facts & Figures by Country
  16. 5.5.1 Europe Chinese Medicine Reference Substance (CMRS) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  18. 5.5.3 Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Chinese Medicine Reference Substance (CMRS) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Chinese Medicine Reference Substance (CMRS) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Chinese Medicine Reference Substance (CMRS) Market Facts & Figures by Country
  41. 5.7.1 South America Chinese Medicine Reference Substance (CMRS) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  43. 5.7.3 South America Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Chinese Medicine Reference Substance (CMRS) Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Chinese Medicine Reference Substance (CMRS) Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Chinese Medicine Reference Substance (CMRS) Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2032)
  2. 6.1.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2021-2032)
  5. 6.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Chinese Medicine Reference Substance (CMRS) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2032)
  2. 7.1.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2021-2032)
  5. 7.2.1 Global Chinese Medicine Reference Substance (CMRS) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Chinese Medicine Reference Substance (CMRS) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Chinese Medicine Reference Substance (CMRS) Value Chain Analysis
  2. 8.1.1 Chinese Medicine Reference Substance (CMRS) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Chinese Medicine Reference Substance (CMRS) Production Mode & Process
  5. 8.2 Chinese Medicine Reference Substance (CMRS) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Chinese Medicine Reference Substance (CMRS) Distributors
  8. 8.2.3 Chinese Medicine Reference Substance (CMRS) Customers
9 Global Chinese Medicine Reference Substance (CMRS) Analyzing Market Dynamics
  1. 9.1 Chinese Medicine Reference Substance (CMRS) Industry Trends
  2. 9.2 Chinese Medicine Reference Substance (CMRS) Industry Drivers
  3. 9.3 Chinese Medicine Reference Substance (CMRS) Industry Opportunities and Challenges
  4. 9.4 Chinese Medicine Reference Substance (CMRS) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst